Terms ending in 2028
Every in-force patent on Dexcom, Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,107,623 | Signal Processing for Continuous Analyte Sensor In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 8,374,667 | Signal Processing for Continuous Analyte Sensor In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 8,133,178 | Analyte Sensor In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 7,657,297 | Implantable Analyte Sensor In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 9,078,626 | Transcutaneous Analyte Sensor In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 9,056,168 | System, Method and Article for Controlling the Dispensing of Insulin In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 8,792,953 | Transcutaneous Analyte Sensor In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 12,237,064 | System, Method and Article for Controlling the Dispensing of Insulin In force · High confidence | Dose Safety | In force | High confidence | |
| US 9,247,901 | Systems and methods for replacing signal artifacts in a glucose sensor data stream In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 9,579,053 | Dual Electrode System for a Continuous Analyte Sensor In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| 27 more term ends in 2028 · Pro | |||||
10 of 37 patents shown. Soonest term end first, then patent number.
Pro members see all 37, including 16 expiring within the 18 months from Nov 15, 2026.
36 of these are in force and held by Dexcom, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.